Application of reagent for detecting content of calprotectin in faeces in preparation of uterine lesion screening kit
A calprotectin and kit technology, which can be used in measurement devices, biological tests, disease diagnosis, etc., can solve problems such as no uterine lesions and calprotectin, and achieve non-invasive screening and good application prospects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Embodiment 1 Screening kit (ELISA) of the present invention
[0027] 1. Composition
[0028] (1) Pre-coated plate: a ninety-six-well plate in which the inner wall and bottom of the wells are coated with anti-human calprotectin rabbit IgG antibody.
[0029] (2) Enzyme-labeled antibody: (30 times concentrated) HRP-labeled anti-human calprotectin rabbit IgG antibody.
[0030] (3) Standard product: calprotectin.
[0031] (4) Buffer: PBS containing 1% BSA, 0.05% Tween 20.
[0032] (5) Chromogen: TMB substrate solution.
[0033] (6) Termination solution: 1N sulfuric acid.
[0034] 2. Sample Preparation
[0035] (1) Collect specimens with a special adherent for sample sampling, place the stool in the center of the unfolded adherent, and pay attention that the stool should not be stained with urine, blood, toilet water, toilet paper and other pollutants;
[0036] (2) Use the sampling stick to insert the stool sample, then put the sampling stick back into the stool samplin...
Embodiment 2
[0050] Example 2 Relationship between uterine lesions and content of fecal calprotectin (FC)
[0051] From June 2019 to September 2019, the inventor performed fecal calprotectin detection on some infertile patients who visited the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (using the calprotectin detection kit (colloidal gold method) of Xiamen Weizheng Biotechnology Co., Ltd. ), including 50 patients with uterine lesions (16 cases of uterine fibroids, 10 cases of endometrial polyps, 11 cases of thin endometrium in the middle luteal body (referred to as "thin endometrium"), and poor blood supply of the endometrium in the middle corpus luteum (referred to as "endometrium") membrane blood supply") in 2 cases, intrauterine adhesions in 5 cases, and adenomyosis in 6 cases). At the same time, healthy adult females were used as controls.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com